Jacobs Bruce N. bought KYMR
September 17, 2025 · Form 4 insider transaction
Jacobs Bruce N. bought 79,220 shares of Kymera Therapeutics, Inc. at $2.08 per share, a transaction worth $164.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
79,220
Price
$2.08
Total value
$164.8K
InsiderJacobs Bruce N.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 17, 2025
Filing dateSeptember 17, 2025
Shares owned after306,629
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.; This number includes 523 shares acquired under the Registrant's employee stock purchase plan on June 2, 2025.